Novo Nordisk says Wegovy pill outperforms Lilly's oral GLP-1 in cross-trial comparison
Novo and Eli Lilly are both trying to shape the narrative of their rival pills, considered to be the start of the next phase of the weight-loss drug era.
Novo Nordisk says Wegovy pill outperforms Lilly's oral GLP-1 in cross-trial comparison basliginda one cikan gelisme: Novo and Eli Lilly are both trying to shape the narrative of their rival pills, considered to be the start of the next phase of the weight-loss drug era.
Fonvera editor notu: Haberin piyasa etkisini izlemek icin ilgili varlik sayfalari ve ekonomik takvim akisi birlikte okunmalidir.